Sutro Biopharma initiates first clinic trial Sutro Initiates First Clinical Trial of CD74-Targeting ADC for Lymphoma & Multiple Myeloma Treatment; The First of a New Generation of Precisely Engineered ADCs:
https://www.prnewswire.com/news-releases/sutro-initiates-first-clinical-trial-of-cd74-targeting-adc-for-lymphoma--multiple-myeloma-treatment-the-first-of-a-new-generation-of-precisely-engineered-adcs-300636962.html
I'm a little surprised we haven't received much of an update on Sutro Biopharma. Last year I believe John Budreski anticipated starting commercial production with Sutro by the end of 2017. In February, ENW stated that they were conducting factory acceptance trials. If they are successful, this would open the door to a number of other pharma projects IMO.